Ligand profile
GTZ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_05294 — Beta-galactosidase 1
Identifiers
Database identifiers and provenance.
- Ligand ID
GTZ- PDB
1jz6- UniProt (similar protein)
P00722- Target protein
- KP13_05294
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 124.5
- −1 ≤ LogP ≤ 5 -3.02
- MW ≤ 500 Da 202.2
- LogP ≤ 5 -3.02
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 124.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@@H]1[C@@H]([C@@H]([C@H](c2n1nnn2)O)O)O)OC([C@@H]1[C@@H]([C@@H]([C@H](c2n1nnn2)O)O)O)O
InChI=1S/C6H10N4O4/c11-1-2-3(12)4(13)5(14)6-7-8-9-10(2)6/h2-5,11-14H,1H2/t2-,3+,4+,5-/m1/s1InChI=1S/C6H10N4O4/c11-1-2-3(12)4(13)5(14)6-7-8-9-10(2)6/h2-5,11-14H,1H2/t2-,3+,4+,5-/m1/s1
UCJXQRFJERKPOZ-MGCNEYSASA-NUCJXQRFJERKPOZ-MGCNEYSASA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02836' 'PF02837' 'PF02929
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand GTZ →
- PDB RCSB structure 1jz6 →
- UniProt UniProt P00722 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “GTZ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05294.
PDB 10
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).